North America Blood Collection Devices Market Forecast to 2030 - Regional Analysis - by Product, Methods, and End User

The North America blood collection devices market is expected to grow from US$ 3.68 billion in 2022 to US$ 5.95 billion by 2030. It is estimated to grow at a CAGR of 6.2% from 2022 to 2030.

Increase in Prevalence of Cancer Worldwide Fuels North America Blood Collection Devices Market

Healthcare facilities across the globe are observing a substantial increase in the prevalence of cancer. According to the National Cancer Institute, cancer is increasingly becoming a global health issue. In 2020, there were 19.3 million new cancer cases, resulting in approximately 10 million cancer-related deaths worldwide. The World Health Organization estimated that, by 2040, there could be 28.9 million new cancer cases globally and ∼16.2 million cancer-related deaths yearly.

The most common method for a blood test for cancer is a liquid biopsy; this method is used for diagnosing non-small cell lung cancer (NSCLC) and screening other types of cancers such as breast, colorectal, prostate, gastrointestinal, and ovarian. As a result, blood collection tubes contribute to the organization's strategy for the early detection of cancer, allowing for quick treatment and enhancing cancer patients' survival rates. Thus, the increasing prevalence of cancer drives the North America blood collection devices market.

North America Blood Collection Devices Market Overview

The North America blood collection devices market is segmented into the US, Canada, and Mexico. The US held the largest share of the North American blood collection devices market in 2022. A rise in the demand for blood collection devices for the diagnostics of COVID-19, increasing incidence of chronic kidney diseases, and high R&D spending by medical device companies and grants provided by governments for research institutes to develop new blood study-related equipment are some of the prominent factors propelling the market growth.

North America Blood Collection Devices Market Revenue and Forecast to 2030 (US$ Million)

North America Blood Collection Devices Market Segmentation

The North America blood collection devices market is segmented into product type, methods, end user, and country.

Based on product type, the North America blood collection devices Market is segmented into blood collection tubes, blood collection needles/holders, blood collection set, and others. The blood collection tubes segment held the largest share of the North America blood collection devices market in 2022.

In terms of methods, the North America blood collection devices Market is bifurcated into manual blood collection and automated blood collection. The manual blood collection segment held a larger share of the North America blood collection devices market in 2022.

By end user, the North America blood collection devices market is segmented into hospitals and pathology laboratories, blood bank, and others. The hospitals and pathology laboratories segment held the largest share of the North America blood collection devices market in 2022.

Based on country, the North America blood collection devices market is segmented into the US, Canada, and Mexico. The US dominated North America blood collection devices market in 2022.

Becton Dickenson and Co, Terumo Corp, Cardinal Health, SARSTEDT AG & Co. KG, NIPRO, Thermo Fisher Scientific Inc, Sekisui Chemical Co Ltd, and Greiner Bio One International GmBH are some of the leading companies operating in the North America blood collection devices market.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America blood collection devices market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in North America blood collection devices market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth North America market trends and outlook coupled with the factors driving the blood collection devices market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.